Alnylam Sweden AB
559086-6686ActiveLeading RNAi therapeutics company developing gene-silencing medicines.
Oversikt
- 5–9
- Ansatte
- 100–500mill SEK
- Omsetning
- 2016
- Grunnlagt
Nøkkelbeslutningstakere
Jeff Poulton
Chief Financial Officer
Hiroshi Okada
President, Alnylam Japan
Bryan Supran
Chief Legal Officer
Pushkal Garg
Chief Research and Development Officer
+19 flere kontakter i Funnelfeedr
Beskrivelse
Alnylam Pharmaceuticals is a leading global biopharmaceutical company dedicated to pioneering RNA interference (RNAi) therapeutics. They focus on developing an innovative class of medicines designed to treat diseases by silencing the specific genes responsible for causing them. This mechanism target...
Tagger
Nøkkelord
Teknologier i bruk
Bedriftsinformasjon
- Bransje
- Partihandel med medicinsk utrustning och apoteksvaror
- Juridisk form
- Aktiebolag
- MVA-nummer
- SE559086668601
Beslutningstakere
23 kontakter i FunnelfeedrJeff Poulton
Chief Financial Officer
Hiroshi Okada
President, Alnylam Japan
Bryan Supran
Chief Legal Officer
Pushkal Garg
Chief Research and Development Officer
Stuart A. Arbuckle
Director
Peter N. Kellogg
Director
Tolga Tanguler
Chief Commercial Officer
Kevin Fitzgerald
Chief Scientific Officer
Margaret A. Hamburg
Director
Timothy Maines
Chief Technical Operations and Quality Officer
Elliott Sigal
Director
Yvonne Greenstreet
Chief Executive Officer
Dennis A. Ausiello
Director
Amy W. Schulman
Chair of the Board of Directors
Melissa McLaughlin
Chief Human Resources Officer
Olivier Brandicourt
Director
Colleen F. Reitan
Director
David E.I. Pyott
Director
Christine Akinc
Chief Corporate Communications Officer
Andre kontakter
Jeffrey Vernon Poulton
Media Contact
Katarzyna Maria Witkos
Media Contact
Piyush Sharma
Chief Ethics & Compliance Officer
Carlos Pagnano
Media Contact
Lignende bedrifter
20 lignende bedrifter i FunnelfeedrAlexion Pharma Nordics AB
10–19 ansattePioneering transformative medicines for the global rare disease community.
Purpose Pharma International AB
5–9 ansatteDeveloping and supplying rare disease treatments across Europe.
PTC Therapeutics Sweden AB
Developing transformative treatments for rare diseases globally for patients.
ASTRAZENECA PLC
1–4 ansatteGlobal science-led pharmaceutical business developing life-changing medicines.
ScandiBio Therapeutics AB
0 ansatteAI-driven biotechnology company developing drugs targeting mitochondrial dysfunction.
Utforsk mer
Spørsmål om Alnylam Sweden AB
Vil du se Funnelfeedr i aksjon?
Book en gratis demo og oppdag hvordan Funnelfeedr hjelper deg med å finne og konvertere dine ideelle kunder.
Book en demo